Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Kotani

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Plos One|March 4, 2014
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected]Kentaro Isoda, Tohru Takeuchi, Takuya Kotani, et al.
Bioscience Reports|November 14, 2012
Cry1Aa binding to the cadherin receptor does not require conserved amino acid sequences in the domain II loopsYuki Fujii, Shiho Tanaka, Manami Otsuki, et al.
Modern Rheumatology|August 4, 2010
Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositisKoji Nagai, Tohru Takeuchi, Takuya Kotani, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 6, 2007
Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab)Tohru Takeuchi, Toyofumi Nakanishi, Yoko Tabushi, et al.
Human Pathology|April 4, 2003
Nasal-type NK/T cell lymphoma of the orbit with distant metastasesHiroko Kuwabara, Motomu Tsuji, Yasuyoshi Yoshii, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 6, 2006
[A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy]Takuya Kotani, Tohru Takeuchi, Michiyo Sakamoto, et al.
Annals of Clinical Biochemistry|June 28, 2008
Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysisYoko Tabushi, Toyofumi Nakanishi, Tohru Takeuchi, et al.
Plos One|August 24, 2018
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritisNao Tokai, Shuzo Yoshida, Takuya Kotani, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 6, 2009
[Successful treatment of early intervention with tacrolimus for a patient with lupus nephritis III+V]Shuzo Yoshida, Takuya Kotani, Tohru Takeuchi, et al.
Journal of Pharmacological Sciences|August 11, 2012
Serum levels of matrix metalloproteinase (MMP) 9, a risk factor for acute coronary syndrome, are reduced independently of serum MMP-3 by anti-TNF-α antibody (infliximab) therapy in patients with rheumatoid arthritisTakuya Kotani, Tohru Takeuchi, Shinji Takai, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Plos One|March 4, 2014
Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected]Kentaro Isoda, Tohru Takeuchi, Takuya Kotani, et al.
Bioscience Reports|November 14, 2012
Cry1Aa binding to the cadherin receptor does not require conserved amino acid sequences in the domain II loopsYuki Fujii, Shiho Tanaka, Manami Otsuki, et al.
Modern Rheumatology|August 4, 2010
Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositisKoji Nagai, Tohru Takeuchi, Takuya Kotani, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 6, 2007
Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab)Tohru Takeuchi, Toyofumi Nakanishi, Yoko Tabushi, et al.
Human Pathology|April 4, 2003
Nasal-type NK/T cell lymphoma of the orbit with distant metastasesHiroko Kuwabara, Motomu Tsuji, Yasuyoshi Yoshii, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 6, 2006
[A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy]Takuya Kotani, Tohru Takeuchi, Michiyo Sakamoto, et al.
Annals of Clinical Biochemistry|June 28, 2008
Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysisYoko Tabushi, Toyofumi Nakanishi, Tohru Takeuchi, et al.
Plos One|August 24, 2018
Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritisNao Tokai, Shuzo Yoshida, Takuya Kotani, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 6, 2009
[Successful treatment of early intervention with tacrolimus for a patient with lupus nephritis III+V]Shuzo Yoshida, Takuya Kotani, Tohru Takeuchi, et al.
Journal of Pharmacological Sciences|August 11, 2012
Serum levels of matrix metalloproteinase (MMP) 9, a risk factor for acute coronary syndrome, are reduced independently of serum MMP-3 by anti-TNF-α antibody (infliximab) therapy in patients with rheumatoid arthritisTakuya Kotani, Tohru Takeuchi, Shinji Takai, et al.
Pageof 11